For twenty years Paula's Choice's advice pages have carried a quiet caveat under its most famous product: the 2% BHA Liquid Exfoliant, the leave-on salicylic acid that made the category, is not the right choice for skin that flushes, stings and reacts. The brand said so itself, repeatedly, and pointed those readers toward its calmer ranges instead. The Skin Perfecting 1% BHA Gentle Exfoliating Gel Toner, launched in mid-2026, is the product that caveat had been asking for — half the acid, a cushioned gel-cream base, and a formula that reads as though someone sat down with the list of reasons sensitive skin gave up on the flagship and addressed them one by one.
The acid comes first, because it is the point. Salicylic acid is sixth in the list at a declared 1 percent, and its mechanism does not change with dose: it is oil-soluble, so it dissolves into the lipid-rich lining of the pore rather than sitting on the surface, and over hours it loosens the bonds holding dead cells to one another and to the pore wall, which is why leave-on BHA clears congestion that scrubs and AHAs cannot reach. At 1 percent it does this more slowly than at 2. That is the whole trade, and for skin that cannot tolerate 2 percent it is a good one, because an exfoliant that can be used every day at a lower dose outperforms one that gets used twice and abandoned. Salicylic acid is also a salicylate, with mild anti-inflammatory activity of its own — the reason low-dose BHA has a place in managing the papules and congestion that accompany some rosacea, and the reason it, rather than an AHA, is the right acid for a product aimed at redness.
The base is where the thinking shows. Instead of the flagship's thin water-and-glycol liquid, the acid here is carried in methylpropanediol with two light, dry emollients — dicaprylyl carbonate and a C15-19 alkane — high in the list, which turns a toner into a soft gel-cream that cushions the acid against the skin and can stand in for a hydrating layer rather than sit on top of one. That texture is why users with reactive skin describe the first application as a non-event, and it is the single most important difference from the 2 percent liquid. Inulin and alpha-glucan oligosaccharide are the prebiotic pair, plant sugars with supplier data on feeding the skin's resident bacteria over the opportunists after a disruption; on a product whose active can shift the surface pH, they are coherent rather than trendy, though the evidence is early. Allantoin sits tenth, the classic anti-irritant placed where it can blunt the tightness a BHA causes in the first weeks. Glycerin, a larch polysaccharide called galactoarabinan that is reported to even out an exfoliant's spread while slowing water loss, and schizophyllan, a mushroom beta-glucan with soothing film-forming properties, round out the support.
Then the redness botanicals, which are the part of the formula that has run ahead of its proof. Albatrellus confluens mushroom extract contains grifolin, which its supplier links to damping the nerve signalling behind stinging and flushing; prickly pear stem extract is a hydrating, anti-inflammatory succulent; laminaria kelp extract adds minerals and a humectant film. Each has laboratory or small-panel support, none has a trial in this gel, and the honest reading of the 'calms visible redness' claim is that a BHA which does not provoke redness will, over weeks, leave skin looking less red than a BHA which does. That is a real benefit; it is a benefit of restraint rather than of an active. Tocopherol and a trace of soybean oil — the only potential allergen on a very clean list — finish the formula, and it is fragrance-free, essential-oil-free and free of denatured alcohol throughout.
In use the pattern is consistent across the few dozen early accounts: no sting, a brief coolness and a faint tack that settles in a minute, smoother texture inside a week or two, and blackheads that shift over four to six weeks rather than two. A minority notice mild tightness in the first week, which a barrier moisturiser over the top resolves. The brand's directions — start every other night, move to daily, sunscreen every morning — are the right ones for any leave-on acid, and the gel's dual role as exfoliant and light hydrator makes the routine shorter, not longer. It pairs sensibly with azelaic acid for redness-prone skin and with a retinoid on alternate nights once tolerated.
The value case is the product's soft spot, and the brand's own line-up makes it visible. Thirty-seven dollars for 100 mL is exactly what the 2 percent liquid costs for 118 mL, which means the half-strength version carries a full-strength price. Some of that is the more expensive base — emollients, prebiotics and botanicals cost more than water and glycol — and some of it is the brand's confidence that the sensitive-skin customer has nowhere else to go for a leave-on BHA this carefully built. That confidence is largely justified; comparable low-dose BHAs from other brands tend to be watery toners aimed at teenage acne rather than barrier-minded gels for adults who flush. But a shopper with resilient skin who simply prefers a gentler pace is paying a premium for slowness, and should know it. A tube lasts about three months at once-daily use.
What cannot be said yet is how it wears over a year on rosacea-prone faces, because the product has only been on sale for a few months and has thirteen brand-site reviews and no retailer pool at the time of writing. The mechanism is among the best-studied in skincare and the formula is fully published, so the low confidence here is about the specific gel, not about salicylic acid. Paula's Choice's track record with fragrance-free, leave-on actives is long enough that the bet is a reasonable one.
The verdict, then, is warm and provisional. This is the BHA for the people the brand spent two decades telling to look elsewhere, built with evident care and priced as though that care were a premium — which, for those people, it is. Anyone whose face tolerates the 2 percent liquid should keep using it. Anyone whose face does not has, at last, a version worth trying.
